Seres Therapeutics
MCRB
#8981
Rank
A$0.15 B
Marketcap
$0.91
Share price
-3.90%
Change (1 day)
-18.46%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -A$0.2 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.22 Billion34.63%
2023 -A$0.17 Billion-59.97%
2022 -A$0.41 Billion289.57%
2021 -A$0.11 Billion-27.3%
2020 -A$0.15 Billion23%
2019 -A$0.12 Billion-30.11%
2018 -A$0.17 Billion9.73%
2017 -A$0.16 Billion-0.74%
2016 -A$0.16 Billion70.96%
2015 -A$88.71 Million257.11%
2014 -A$24.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.41 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.43 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.71 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA